Fostamatinib Disodium News
Fostamatinib Disodium currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Fostamatinib Disodium with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Tavlesse is indicated for the treatment of chronic immune thrombocytopenia (ITP) in adult patients who are refractory to other treatments.
- Evidence level: L5
- Predicted indications (20):
- thrombocytopenia due to immune destruction (99.8%)
- autosomal thrombocytopenia with normal platelets (99.5%)
- non-syndromic esophageal malformation (99.0%)
- syndromic constitutional thrombocytopenia (99.0%)
- glaucoma (98.7%)
- biotin metabolic disease (98.7%)
- primary hereditary glaucoma (98.6%)
- open-angle glaucoma (98.5%)
- filariasis (98.4%)
- vitamin deficiency disorder (98.2%)
- esophageal disease (97.9%)
- neonatal thrombocytopenia (97.9%)
- tinea nigra (97.8%)
- anogenital human papillomavirus infection (97.6%)
- herpes simplex virus keratitis (97.6%)
- HER2 positive breast carcinoma (97.5%)
- photosensitivity disease (97.5%)
- female breast carcinoma (97.0%)
- esotropia (97.0%)
- progesterone-receptor negative breast cancer (96.6%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.